Skip to main content
See the bias in every story
Published • loading... • Updated

Thermo Fisher Scientific Q3 Earnings Call Highlights

Thermo Fisher lifted full-year revenue and EPS targets after stronger pharma and biotech demand drove 6% organic growth and a 24.5% adjusted margin.

Summary by MarketBeat
Thermo Fisher Scientific (NYSE:TMO) reported third-quarter revenue growth of 9% to $12.14 billion, supported by 6% organic growth, acquisitions and foreign-exchange effects. Adjusted earnings per share rose 15% to $6.68, while adjusted operating income increased 15% to $2.97 billion. Chairman and C

7 Articles

(Teleborsa) - Thermo Fisher Scientific, a U.S. multinational company active in the field of life sciences and services for scientific research, closed the third quarter of 2026 with revenues...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

thecerbatgem.com broke the news on Wednesday, October 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal